Showing 1 - 12 results of 12 for search 'Cheryl Ho', query time: 0.04s
Refine Results
-
1
FDA Accelerated Approval for Malignant Hematology and Oncology Indications in the Canadian Environment by Cheryl Ho, Howard J. Lim, Dean A. Regier
Published 2022-01-01
Article -
2
-
3
-
4
-
5
-
6
-
7
-
8
Disparate Time-to-Treatment and Varied Incidence of Actionable Non-Small Cell Lung Cancer Molecular Alterations in British Columbia: A Historical Cohort Study by Roy Avraham Hilzenrat, Stephen Yip, Barbara Melosky, Cheryl Ho, Janessa Laskin, Sophie Sun, James J. Choi, Anna L. McGuire
Published 2022-12-01
Article -
9
-
10
A perspective on life-cycle health technology assessment and real-world evidence for precision oncology in Canada by Dean A. Regier, Samantha Pollard, Melanie McPhail, Tania Bubela, Timothy P. Hanna, Cheryl Ho, Howard J. Lim, Kelvin Chan, Stuart J. Peacock, Deirdre Weymann
Published 2022-10-01
Article -
11
Beyond PACIFIC: Real-World Outcomes of Adjuvant Durvalumab According to Treatment Received and PD-L1 Expression by Marie-Hélène Denault, Jamie Feng, Shelley Kuang, Aria Shokoohi, Bonnie Leung, Mitchell Liu, Eric Berthelet, Janessa Laskin, Sophie Sun, Tina Zhang, Cheryl Ho, Barbara Melosky
Published 2023-08-01
Article -
12
Prediction of Disease Progression to Upfront Pembrolizumab Monotherapy in Advanced Non-Small-Cell Lung Cancer with High PD-L1 Expression Using Baseline CT Disease Quantification an... by Ali Silver, Cheryl Ho, Qian Ye, Jianjun Zhang, Ian Janzen, Jessica Li, Montgomery Martin, Lang Wu, Ying Wang, Stephen Lam, Calum MacAulay, Barbara Melosky, Ren Yuan
Published 2023-06-01
Article